XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Operating cash flows:      
Net income before non-controlling interests $ 3,174 $ 2,046 $ 1,773
Adjustments to reconcile net income to cash provided by operations:      
Depreciation and amortization of fixed assets and capitalized software 382 390 333
Amortization of intangible assets 365 351 314
Non cash lease expense 327 355 315
Adjustments and payments related to contingent consideration assets and liabilities 27 (22) 27
Gain on consolidation of entity (267) 0 0
Charge for early extinguishment of debt 0 0 32
(Benefit) provision for deferred income taxes (63) 40 84
Net (gain) loss on investments (61) 22 (22)
Net (gain) loss on disposition of assets (33) 24 56
Share-based compensation expense 348 290 252
Change in fair value of acquisition-related derivative contracts 0 0 8
Changes in assets and liabilities:      
Net receivables (252) (75) (130)
Other current assets (166) (66) (13)
Other assets (215) 86 (1)
Accounts payable and accrued liabilities 225 241 120
Accrued compensation and employee benefits 527 207 154
Accrued income taxes (45) 60 42
Contributions to pension and other benefit plans in excess of current year credit (372) (356) (369)
Other liabilities 2 108 (172)
Operating lease liabilities (349) (351) (327)
Effect of exchange rate changes (38) 32 (115)
Net cash provided by operations 3,516 3,382 2,361
Financing cash flows:      
Purchase of treasury shares (1,159) 0 (485)
Borrowings from term-loan and credit facilities 0 1,000 300
Proceeds from issuance of debt 743 737 6,459
Repayments of debt (1,016) (2,515) (1,064)
Payments for early extinguishment of debt 0 0 (585)
Purchase of non-controlling interests 0 (3) (80)
Acquisition-related derivative payments 0 0 (337)
Shares withheld for taxes on vested units – treasury shares (101) (132) (89)
Issuance of common stock from treasury shares 161 132 158
Payments of deferred and contingent consideration for acquisitions (117) (122) (65)
Receipts of contingent consideration for dispositions 71 0 0
Distributions of non-controlling interests (36) (34) (16)
Dividends paid (1,026) (943) (890)
Change in fiduciary liabilities 1,183 955 1,025
Net cash (used for) provided by financing activities (1,297) (925) 4,331
Investing cash flows:      
Capital expenditures (406) (348) (421)
Net sales (purchases) of long-term investments 18 107 183
Purchase of equity investment (5) 0 (91)
Dispositions 84 98 229
Acquisitions, net of cash and cash held in a fiduciary capacity acquired (859) (647) (4,229)
Other, net 4 (3) (66)
Net cash used for investing activities (1,164) (793) (4,395)
Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity (355) 511 135
Increase in cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity 700 2,175 2,432
Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of year 10,674 8,499 6,067
Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of year 11,374 10,674 8,499
Cash and cash equivalents 1,752 2,089 1,155
Cash and cash equivalents held in a fiduciary capacity 9,622 8,585 7,344
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity $ 11,374 $ 10,674 $ 8,499